Association of survival and disease progression with chromosomal instability: A genomic exploration of colorectal cancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 106, Issue 17, 2009, Pages 7131-7136

  Sheffer, Michal ^a   Bacolod, Manny D ^b   Zuk, Or ^c   Giardina, Sarah F ^b   Pincas, Hanna ^b   Barany, Francis ^b   Paty, Philip B ^d   Gerald, William L ^d   Notterman, Daniel A ^e   Domany, Eytan ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c HARVARD UNIVERSITY   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e PRINCETON UNIVERSITY   (United States)

Author keywords

Colon cancer; DNA copy number; Gene expression; SNP arrays

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; FIBROBLAST GROWTH FACTOR 6; GELATINASE B; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE LYN; SCATTER FACTOR RECEPTOR; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME UBE2C; UNCLASSIFIED DRUG; VASCULOTROPIN A; UNTRANSLATED RNA;

ADENOCARCINOMA; ARTICLE; AURKA GENE; CANCER STAGING; CHROMOSOMAL INSTABILITY; CHROMOSOME 14Q; CHROMOSOME 15Q; CHROMOSOME 17P; CHROMOSOME 18; CHROMOSOME 20P; CHROMOSOME 22Q; CHROMOSOME 7; CHROMOSOME 8Q; CHROMOSOME DELETION; COLORECTAL ADENOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DISEASE COURSE; GENE; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN TISSUE; METASTASIS; ONCOGENE MYB; ONCOGENE MYC; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS; SURVIVAL; COLORECTAL TUMOR; DNA MICROARRAY; GENE DOSAGE; GENE EXPRESSION REGULATION; GENETICS; HUMAN GENOME; OXIDATION REDUCTION REACTION; PATHOLOGY; PHOSPHORYLATION; SURVIVAL RATE;

CHROMOSOMAL INSTABILITY; CHROMOSOME DELETION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; GENE DOSAGE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATION-REDUCTION; PHOSPHORYLATION; POLYMORPHISM, SINGLE NUCLEOTIDE; RNA, UNTRANSLATED; SURVIVAL RATE;

EID: 66349121667     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0902232106     Document Type: Article

References (41)

1. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61:759-767.
2. Lengauer C, Kinzler KW, Vogelstein B (1998) Genetic instabilities in human cancers. Nature 396:643-649.
3. Jones AM, et al. (2005) Array-CGH analysis of microsatellite-stable, near-diploid bowel cancers and comparison with other types of colorectal carcinoma. Oncogene 24:118-129.
4. Kurashina K, et al. (2008) Chromosome copy number analysis in screening for prognosis-related genomic regions in colorectal carcinoma. Cancer Sci 99:1835-1840.
5. Leslie A, et al. (2003) Mutations of APC, K-ras, and p53 are associated with specific chromosomal aberrations in colorectal adenocarcinomas. Cancer Res 63:4656-4661.
6. Albertson DG, Collins C, McCormick F, Gray JW (2003) Chromosome aberrations in solid tumors. Nat Genet 34:369-376.
7. Tsafrir D, et al. (2006) Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66:2129-2137.
8. Platzer P, et al. (2002) Silence of chromosomal amplifications in colon cancer. Cancer Res 62:1134-1138.
9. Beroukhim R, et al. (2007) Assessing the significance of chromosomal aberrations in cancer: Methodology and application to glioma. Proc Natl Acad Sci USA 104:20007-20012.
10. Ferrara N (2004) Vascular endothelial growth factor: Basic science and clinical progress. Endocr Rev 25:581-611.
11. Eswarakumar VP, Lax I, Schlessinger J (2005) Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev 16:139-149.
12. Goel A, et al. (2004) Frequent inactivation of PTEN by promoter hypermethylation in microsatellite instability-high sporadic colorectal cancers. Cancer Res 64:3014-3021.
13. Buffart TE, et al. (2005) DNA copy number changes at 8q11-24 in metastasized colorectal cancer. Cell Oncol 27:57-65.
14. Bates RC, Edwards NS, Burns GF, Fisher DE (2001) A CD44 survival pathway triggers chemoresistance via lyn kinase and phosphoinositide 3-kinase/Akt in colon carcinoma cells. Cancer Res 61:5275-5283.
15. Subramaniam V, et al. (2007) CD44 regulates cell migration in human colon cancer cells via Lyn kinase and AKT phosphorylation. Exp Mol Pathol 83:207-215.
16. Furge KA, Zhang YW, Vande Woude GF (2000) Met receptor tyrosine kinase: Enhanced signaling through adapter proteins. Oncogene 19:5582-5589.
17. Rundhaug JE (2005) Matrix metalloproteinases and angiogenesis. J Cell Mol Med 9:267-285.
18. Sala A (2005) B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer. Eur J Cancer 41:2479-2484.
19. Wagner KW, et al. (2004) Overexpression, genomic amplification and therapeutic potential of inhibiting the UbcH10 ubiquitin conjugase in human carcinomas of diverse anatomic origin. Oncogene 23:6621-6629.
20. Katayama H, Brinkley WR, Sen S (2003) The Aurora kinases: Role in cell transformation and tumorigenesis. Cancer Metastasis Rev 22:451-464.
21. Gerhardt A, et al. (2004) Tissue expression and sero-reactivity of tumor-specific antigens in colorectal cancer. Cancer Lett 208:197-206.
22. Farrell C, et al. (2008) Somatic mutations to CSMD1 in colorectal adenocarcinomas. Cancer Biol Ther 7:609-613.
23. Hirokawa YS, et al. (2007) High level expression of STAG1/PMEPA1 in an androgen-independent prostate cancer PC3 subclone. Cell Mol Biol Lett 12:370-377.
24. Martinez-Calvillo S, et al. (2007) Characterization of the RNA polymerase II and III complexes in Leishmania major. Int J Parasitol 37:491-502.
25. Firestein R, et al. (2008) CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455:547-451.
26. Cummins JM, et al. (2006) The colorectal microRNAome. Proc Natl Acad Sci USA 103:3687-3692.
27. Royo H, Bortolin ML, Seitz H, Cavaille J (2006) Small non-coding RNAs and genomic imprinting. Cytogenet Genome Res 113:99-108.
28. Carter SL, et al. (2006) A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38:1043-1048.
29. Hertzberg L, et al. (2007) Prediction of chromosomal aneuploidy from gene expression data. Genes Chromosomes Cancer 46:75-86.
30. Al-Mulla F, et al. (2006) Metastatic recurrence of early-stage colorectal cancer is linked to loss of heterozygosity on chromosomes 4 and 14q. J Clin Pathol 59:624-630.
31. Bardi G, et al. (2004) Tumor karyotype predicts clinical outcome in colorectal cancer patients. J Clin Oncol 22:2623-2634.
32. Duensing A, Duensing S (2005) Guilt by association? p53 and the development of aneuploidy in cancer. Biochem Biophys Res Commun 331:694-700.
33. Hupe P, et al. (2004) Analysis of array CGH data: From signal ratio to gain and loss of DNA regions. Bioinformatics 20:3413-3422.
34. Dennis G, Jr., et al. (2003) DAVID: Database for annotation, visualization, and integrated discovery. Genome Biol 4:P3.
35. Hosack DA, et al. (2003) Identifying biological themes within lists of genes with EASE. Genome Biol 4:R70.
36. Tsafrir D, et al. (2005) Sorting points into neighborhoods (SPIN): Data analysis and visualization by ordering distance matrices. Bioinformatics 21:2301-2308.
37. Denko NC (2008) Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer 8:705-713.
38. Warburg O (1956) On respiratory impairment in cancer cells. Science 124:269-270.
39. Bardos JI, Ashcroft M (2004) Hypoxia-inducible factor-1 and oncogenic signalling. Bioessays 26:262-269.
40. Gogvadze V, Orrenius S, Zhivotovsky B (2008) Mitochondria in cancer cells: What is so special about them? Trends Cell Biol 18:165-173.
41. Bacolod MD, et al. (2008) The signatures of autozygosity among patients with colo-rectal cancer. Cancer Res 68:2610-2621.